Related Experiment Video
Updated: Aug 2, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Combination chemotherapy in generalized Hodgkin's disease
British Medical Journal
|July 4, 1970
Summary
This study shows that combination chemotherapy, including mustine hydrochloride, vinblastine, procarbazine, and prednisolone, is effective for generalized Hodgkin
Area of Science:
- Oncology
- Hematology
- Clinical Trials
Background:
- Hodgkin's disease is a cancer of the lymphatic system.
- Previous treatments for Hodgkin's disease include radiotherapy and chemotherapy.
Purpose of the Study:
- To evaluate the efficacy of a combination chemotherapy regimen for generalized Hodgkin's disease.
- To assess the impact of prior treatments on treatment response.
Main Methods:
- Fifty-two patients with generalized Hodgkin's disease were treated with mustine hydrochloride, vinblastine, procarbazine, and prednisolone.
- Patients were stratified based on prior treatment history (none, radiotherapy only, or chemotherapy with or without radiotherapy).
Main Results:
- Complete remission rates were 86% in treatment-naive patients, 79% after radiotherapy, and 35% after prior chemotherapy.
- 22 out of 30 patients achieving complete remission remained disease-free for 4-22 months.
- Treatment was rapid with manageable toxicity, except in patients with continuous prior cytotoxic drug exposure.
Conclusions:
- Combination chemotherapy demonstrates significant efficacy in generalized Hodgkin's disease, particularly in previously untreated or radiotherapy-treated patients.
- Prior chemotherapy may reduce the effectiveness of subsequent combination regimens.
- A comparative trial of radiotherapy versus combination therapy for Stage III Hodgkin's disease is warranted.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.